H.R. 2577 · 108th Congress
To require the Comptroller General to conduct a study and submit to Congress a report on price controls of foreign governments on pharmaceuticals.
- Stage
- In committee
- Sponsor
- Michael Burgess
- Introduced
- 2003-06-24
- Latest action
- 2003-07-02 · Referred to the Subcommittee on Trade.
Subjects
Congress
Health
Foreign trade and international finance
Commerce
Economics and Public Finance
Congressional reporting requirements
International Affairs
Congressional investigations
Trade negotiations
Drugs
Prescription pricing
Nontariff trade barriers
Drug industry
Price regulation